DBV Technologies (DBVT) Debt Ratio (2015 - 2019)

DBV Technologies (DBVT) reported Debt Ratio of 0.01 for Q4 2019, down 62.76% year-over-year from 0.01 in Q4 2018, and down 62.76% quarter-over-quarter from 0.01 in Q4 2018.

DBV Technologies (DBVT) Debt Ratio (2015 - 2019) Analysis & Trends

DBV Technologies (DBVT) has 5 years of Debt Ratio data on file, last reported at 0.01 in Q4 2019.

  • Debt Ratio for Q4 2019 came in at 0.01, down 62.76% year-over-year; the trailing twelve-month figure through Dec 2018 was 0.01 (down 38.16% YoY), and the FY2019 annual result was 0.01, down 63.37% from the prior year.
  • Debt Ratio slipped to 0.01 in Q4 2019 per DBVT's latest filing, from 0.01 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.02 in Q4 2017 and troughed at 0.01 in Q4 2019.
  • A 5-year average of 0.01 and a median of 0.01 in 2018 frame the typical range for Debt Ratio.
  • The sharpest annual moves came in 2017 and 2019: Debt Ratio soared 44.62% in 2017, then slumped 62.76% in 2019.
  • A 5-year view of Debt Ratio shows it stood at 0.01 in 2015, then gained by 14.42% to 0.02 in 2016, then soared by 44.62% to 0.02 in 2017, then sank by 38.16% to 0.01 in 2018, then sank by 62.76% to 0.01 in 2019.
  • Business Quant data shows DBVT's Debt Ratio at 0.01 in Q4 2019, 0.01 in Q4 2018, and 0.02 in Q4 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.18
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 DBV Technologies 6.63 Bn 6.41 Bn -3.90 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2019 0.01
Dec 31, 2018 0.01
Dec 31, 2017 0.02
Dec 31, 2016 0.02
Dec 31, 2015 0.01